INBX Operating Cash Flow Growth
Inhibrx Biosciences Inc · Operating Cash Flow Growth
INBX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported5.69%period ending
INBX TTM Cash from Operations YoY % (-10.41% → 5.69%)
Year-over-year change
High-resolution chart · PNG
INBX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 5.6919% | |
| 21.123% | |
| 33.2366% | |
| 30.8988% | |
| 39.5833% | |
| 22.7161% | |
| -7.8229% | |
| -34.6742% | |
| -77.1358% | |
| -87.6989% | |
| -56.3768% | |
| -43.5721% | |
| -44.9411% | |
| -34.6699% | |
| -43.5467% | |
| -46.83% | |
| -23.0003% | |
| -37.5844% | |
| -67.4512% | |
| -64.1742% | |
| -133.3471% | |
| -83.6176% | |
| -49.5308% | |
| -64.5209% | |
| 20.0611% | |
| -22.6921% | |
| -10.4116% |